USPTO serial 79337526
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christian D. Abel
Christian D. Abel Onsagers ASPO Box 1813 VikaOslo, 0123NORWAY| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and veterinary preparations for treatment of immune diseases, cancer, tumors, infectious diseases and viral diseases; sanitary preparations for medical purposes; dietary supplements for humans and animals; Immunotherapeutic preparations, namely, vaccines against immune diseases, cancer, tumors, infectious diseases and viral diseases; Pharmaceutical preparations for the treatments of cancer; Pharmaceutical preparations for treatment of tumors; anti-cancer pharmaceutical preparations for injections; Radioactive pharmaceutical preparations for radiation treatment; Radioactive substances for medical purposes; Diagnostic preparations for medical and veterinary purposes; pharmaceutical preparations for treatment of infectious diseases; pharmaceutical preparations for treatment of viral diseases; Biological preparations for medical purposes, namely, the treatment of immune diseases, cancer, tumors, infectious diseases and viral diseases; biological preparations for treatment of cancer; biological preparations for treatment of infectious diseases; biological preparations for treatment of viral diseases; vaccines; immunostimulants; pharmaceutical preparations for treatment of allergies; biological preparations for treatment of allergies; pharmaceutical preparations for treatment of autoimmune diseases; biological preparations for treatment of autoimmune diseases | ACTIVE | — |
| 009 | Laboratory instruments and apparatus for analyzing nucleic acids, DNA, RNA, peptides, proteins, lipids, polysaccharides, antigens and antigen presenting cells, for preparation, filtration and separation of nucleic acids, DNA, RNA, peptides, proteins, lipids, poly saccharides, antigens and antigen presenting cells, and for chromatography, not for medical purposes; Downloadable medical software and mobile application for use with immunotherapy, namely, compiling medical data, analyzing test results, and evaluating medical data; Downloadable medical software for designing pharmaceuticals; Downloadable medical software and mobile applications allowing user selection of antigens for designing personalized medicines; Downloadable medical software and mobile applications for user selection of antigens for designing pharmaceuticals | ACTIVE | — |
| 035 | Promoting the goods of others, namely, pharmaceutical products, biological preparations, medical diagnostic products, vaccines, anti-cancer pharmaceutical products, and immunotherapeutic pharmaceuticals and products; retail store services featuring pharmaceutical products, biological preparations, medical diagnostic products, vaccines, anti-cancer pharmaceutical products, and immunotherapeutic pharmaceuticals and products | ACTIVE | — |
| 040 | Treatment of biological materials for use in production of pharmaceutical preparations by means of culturing, expansion, filtration, purification, addition of pharmaceutical excipients and carriers, as well as the portioning and packing of those materials; processing and custom manufacturing of pharmaceuticals for others; processing and custom manufacturing of preparations for cancer treatment, preparations for treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and medical diagnostic preparations for others | ACTIVE | — |
| 042 | Scientific and technological laboratory services and research and design relating thereto, all in the field of pharmaceuticals and vaccines; Industrial analysis and research services in the field of pharmaceuticals and vaccines; design and development of computer hardware and software; design, research and development of pharmaceuticals, preparations for cancer treatment, preparations for treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and medical diagnostic preparations; design and development of medical diagnostic equipment and medical instruments; research and development in the field of medical diagnostic preparations; design and development of medical techniques; Pharmaceutical research and development; Scientific and technological consultancy related to the aforesaid services | ACTIVE | — |
| 044 | Providing information in the field of medicine and health in related to the treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; medical and pharmaceutical consulting services in the field of treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; Provision of medical services by health care professions, namely, hygiene care for human beings in the field of treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; medical clinic services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 26, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 5, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 11, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 11, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 10, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 10, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 10, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 3, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 13, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 25, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 25, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 5, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 20, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 20, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 20, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 12, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 12, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 12, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 12, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 22, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 22, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 22, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 4, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 22, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 26, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 26, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 20, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 19, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 8, 2022 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 12, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |